Animal Biotechnology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Animal Biotechnology Market Companies and the market is segmented by Product Type (Diagnostic Tests, Reproductive & Genetic Products, Vaccines, and Drugs), Application (Development of Animal Pharmaceuticals, Food Safety and Drug Development, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Animal Biotechnology Market Size

Single User License
Team License
Corporate License
Book before:
Animal Biotechnology Market Size
share button
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR 4.70 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players


*Disclaimer: Major Players sorted in no particular order


Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License


Team License


Corporate License

Book before:

Animal Biotechnology Market Analysis

The global animal biotechnology market is expected to register a CAGR of 4.7% during the forecast period (2022 - 2027).

As per the data from the Centers for Disease Control and Prevention (CDC) updated in April 2022, cats, dogs, and a few other types of animals were at potential risk of acquiring the coronavirus. Furthermore, according to the study published in PLOS ONE, titled "Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil" in April 2021, between May and October 2020, 39 patients' pets (29 dogs and 10 cats) were examined. SARS-CoV-2 infection or seropositivity was found in nine dogs (31%) and four cats (40%) from ten (47.6%) households. This is expected to drive the growth of the animal biotechnology market due to the adoption of vaccines for COVID-19 in animals.

Globally, biotechnology has improved animal feed, produced vaccines for livestock, and improved diagnostics for diseases such as bovine spongiform encephalopathy (BSE), foot-and-mouth disease, and salmonella. A significant rise in focus on cloning and transgenic animals is expected to propel market growth. For instance, according to the article published in IOP Science in 2020, titled "The Role of Biotechnology in Animal Production," biotechnology is widely utilized in animal production to increase not just the number of livestock animals to meet global demand for animal products but also for endangered species to improve reproduction and maintain present levels of biodiversity and genetic variation.

The rising initiative to educate on animal genetic testing is further expected to drive the growth of this market. For instance, in June 2020, the Veterinary Genetics Laboratory (VGL) at the UC Davis School of Veterinary Medicine launched an updated and advanced website along with several new tests for the veterinary community. In addition, in October 2021, Embark Veterinary, Inc., launched its DNA test for purebred dogs. The kit offers purebred owners unique, actionable health information that will help determine diagnostic, monitoring, and treatment plans that can easily be shared with a veterinarian. Such initiatives will lead to increased adoption of genetic testing for the care of animal health, thereby driving the market growth.

The market players in the animal biotechnology market are involved in various growth strategies, such as collaborations, partnerships, agreements, and mergers and acquisitions, to enhance their market presence. For instance, in January 2020, Merck Animal Health signed a partnership agreement with Automazioni VX, Inc. (US), aiming to introduce Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be utilized in combination with Merck Animal Health's Innovax range of vaccines, which are used for protection against infectious diseases.

In addition to the aforementioned factors, increasing R&D activities by major market players and the rising number of regulatory approvals are expected to propel the market's growth over the forecast period. However, ethical issues associated with animal biotechnology products are expected to hinder the growth of the market over the forecast period.

Animal Biotechnology Market Trends

This section covers the major market trends shaping the Animal Biotechnology Market according to our research experts:

Vaccines Segment is Expected to Show Significant Growth Over the Forecast Period

The vaccines segment is expected to show significant growth over the forecast period in the animal biotechnology market.

The growth of the vaccine segment is mainly attributed to the rising burden of animal diseases. These diseases are naturally transmitted from animals to humans due to contaminated food and water consumption or direct contact with infected animals or humans. Vaccination is an effective way to reduce disease burden in animals, and it plays an essential role in preventive healthcare and disease control.

According to the study published in Frontiers in Bioengineering and Biotechnology, titled 'Applications of Nanovaccines for Disease Prevention in Cattle' in December 2020, vaccines are one of the most effective strategies for preventing and controlling infectious illnesses in cattle. Nanoparticle-based vaccine platforms (nano vaccines) have recently gained traction as viable alternatives to more traditional vaccine platforms. The wide use of vaccines to prevent and control animal diseases is therefore expected to drive market growth.

In addition, the rise in vaccine launches for animals by the key market players is expected to drive this segment growth over the forecast period. In May 2021, Boehringer Ingelheim India launched its poultry vaccine VAXXITEK HVT+IBD. An innovative recombinant vaccine, VAXXITEK HVT+IBD, is a single-shot vaccine, ensuring life-long protection for all types of production chickens, namely broiler, layer, and breeder.

Moreover, in December 2021, Indian Immunologicals Ltd (IIL) launched the Goat Pox Vaccine (Raksha Goat Pox), which is expected to help Control Goat Pox disease. Such launches will lead to increased adoption of vaccines, driving this segment growth.

Therefore, the above-mentioned factors are expected to drive this segment growth over the forecast period.

Animal Biotechnology Market Trends

North America Holds A Major Market Share And Is Expected To Do The Same Over The Forecast Period

The major factors driving the animal biotechnology market include the increase in the adoption of companion animals, the increasing prevalence of diseases such as zoonosis, the availability of advanced veterinary healthcare infrastructure in the region, and the presence of key market players in North America.

In the United States, the COVID-19 pandemic directly or indirectly disrupted activities to keep livestock animals healthy, including preventing and controlling diseases. Due to labor shortages, there was a reduced capacity to work on animal health activities such as vaccination, maintaining good biosecurity, medical treatment of sick animals, and prophylactic treatment. For instance, according to the study published in Frontiers in Veterinary Science, titled "COVID-19 Effects on Livestock Production: A One Welfare Issue" in September 2020, many processing companies in the United States (US) shut down when major outbreaks were discovered, placing pressure on the pig and poultry industries in particular. 

There are also increasing initiatives and campaigns implemented by the Canadian government to promote animal health, which may boost the demand for animal diagnostics in the coming years. For instance, in January 2021, through the Canadian Agricultural Partnership, the governments of Canada and Ontario funded up to CAD 4 million to increase farmers' access to veterinary services whenever needed. Furthermore, the data published by the American Pet Products Association in 2021 stated that the total pet healthcare expenditure has been estimated to be USD 109.6 billion in 2021, while that in 2020 was found to be USD 103 billion. This will further drive the market growth due to the adoption of biotech products for pet care.

Moreover, in April 2020, Heska Corporation acquired Scil Animal Care to emerge as a global leader in veterinary point-of-care diagnostics. In addition, the growing awareness about animal health among pet owners, rising government initiatives, and rise in product innovation (such as new vaccine launches) are other factors propelling the growth of the animal biotechnology market in North America.

Therefore, owing to the aforementioned factors, the market is expected to grow over the forecast period.

Animal Biotechnology Market Share

Animal Biotechnology Industry Overview

The animal biotechnology market is moderately consolidated and consists of a few major players who are currently dominating the market. The market is driven due to the factors such as a rise in product launches and a rise in partnerships, among others. Some of the market players include Bayer AG, Boehringer Ingelheim GmbH, Merck & Co., Inc., Zoetis Inc., Virbac, Biogenesis Bago, Idexx Laboratories and others.

Animal Biotechnology Market Leaders

  1. Boehringer Ingelheim GmbH

  2. Merck & Co.,Inc.

  3. Zoetis Inc.

  4. Virbac

  5. Elanco

*Disclaimer: Major Players sorted in no particular order

bookmark Need More Details on Market Players and Competitors?
Download PDF

Animal Biotechnology Market News

  • In April 2022, Poultry vaccine maker Hester Bio entered pet care. The company is now looking to add dermatology, nutrition, grooming, anti-infective, and specialty products to the pet care segment.
  • In April 2022, Cadila Pharma launched the world's one of the first novel 3-dose vaccines against rabies. The three-dose vaccine, named 'ThRabis', is a recombinant nano-particle-based G protein vaccine that is prepared using Virus-like Particle technology.

Animal Biotechnology Market Report - Table of Contents


    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing R&D Activities by Major Market Players

      2. 4.2.2 Growing Focus Towards Cloning & Transgenic Animals

    3. 4.3 Market Restraints

      1. 4.3.1 Ethical Issues Associated with Animal Biotechnology Products

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product Type

      1. 5.1.1 Diagnostic Tests

      2. 5.1.2 Reproductive & Genetic Products

      3. 5.1.3 Vaccines

      4. 5.1.4 Drugs

    2. 5.2 By Application

      1. 5.2.1 Development of Animal Pharmaceuticals

      2. 5.2.2 Food Safety and Drug Development

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Merck & Co.,Inc.

      2. 6.1.2 Boehringer Ingelheim.

      3. 6.1.3 Randox Laboratories

      4. 6.1.4 Zoetis

      5. 6.1.5 Virbac

      6. 6.1.6 Elanco

      7. 6.1.7 Biogénesis Bagó

      8. 6.1.8 Santa Cruz Biotechnology, Inc

      9. 6.1.9 Idexx Laboratories

      10. 6.1.10 Innovative Diagnostics (IDVet)

      11. 6.1.11 Heska Corporation

      12. 6.1.12 INDICAL Bioscience GmbH

      13. 6.1.13 BioChek BV

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
bookmark You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Animal Biotechnology Industry Segmentation

As per the scope of the report, animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genomes are modified), to make them suitable for pharmaceutical, industrial, or agricultural applications. The animal biotechnology market is segmented by Product Type (Diagnostic Tests, Reproductive & Genetic Products, Vaccines, and Drugs), Application (Development of Animal Pharmaceuticals, Food Safety, and Drug Development, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Type
Diagnostic Tests
Reproductive & Genetic Products
By Application
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Other Applications
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America
customize-icon Need A Different Region Or Segment?
Customize Now

Animal Biotechnology Market Research FAQs

The Global Animal Biotechnology Market is projected to register a CAGR of 4.70% during the forecast period (2024-2029)

Boehringer Ingelheim GmbH, Merck & Co.,Inc., Zoetis Inc., Virbac and Elanco are the major companies operating in the Global Animal Biotechnology Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Animal Biotechnology Market.

The report covers the Global Animal Biotechnology Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Animal Biotechnology Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Animal Biotechnology Industry Report

Statistics for the 2024 Animal Biotechnology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Animal Biotechnology analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Animal Biotechnology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)